Quality of life (QoL) and symptoms in transfusion-dependent patients with myelodysplastic syndromes (MDS) undergoing oral chelation therapy

被引:0
|
作者
Efficace, Fabio [1 ]
Cottone, Francesco [1 ]
Vignetti, Marco [2 ]
Mandelli, Franco [1 ]
Angelucci, Emanuele [3 ]
机构
[1] GIMEMA, Italian Grp Adult Hematol Dis, Rome, Italy
[2] GIMEMA Data Ctr, Hlth Outcomes Res Unit, Rome, Italy
[3] Osped Oncol Riferimento Reg A Businco, Rome, Italy
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
3092
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes
    Jansen, AJG
    Essink-Bot, ML
    Beckers, EAM
    Hop, WCJ
    Schipperus, MR
    van Rhenen, DJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (02) : 270 - 274
  • [2] Quality of life (QoL) and symptoms in patients with myelodysplastic syndromes (MDS). Investigating the role of transfusion dependency in an International study
    Efficace, Fabio
    Gaidano, Gianluca
    Stauder, Reinhard
    Caocci, Giovanni
    Voso, Maria Teresa
    Bowen, David
    Selleslag, Dominik
    Di Tucci, Anna Angela
    Lunghi, Monica
    Breccia, Massimo
    QUALITY OF LIFE RESEARCH, 2012, 21 : 8 - 9
  • [3] IRON OVERLOAD AND IRON CHELATION THERAPY WITH DEFERASIROX IN TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Del Corso, L.
    Bacigalupo, A.
    Balleari, E.
    Bellodi, A.
    Calzamiglia, T.
    Da Col, A.
    D'elia, P.
    Dominietto, A.
    Favorini, S.
    Forni, G.
    Galimberti, S.
    Ghio, M.
    Ghio, R.
    Salvetti, C.
    Ubezio, G.
    Vignolo, L.
    Molinari, E.
    Ghiso, A.
    Drousseau, M.
    Simonetti, F.
    Goretti, R.
    Tassara, R.
    Racchi, O.
    Scudeletti, M.
    Arboscello, E.
    Gianluca, F.
    LEUKEMIA RESEARCH, 2015, 39 : S150 - S150
  • [4] Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany
    Kuehne, F.
    Mittendorf, T.
    Voelkl, M.
    Lipp, R.
    Germing, U.
    Vioni-Niemeyer, A.
    von der Schulenburg, J. M.
    LEUKEMIA RESEARCH, 2007, 31 : S111 - S111
  • [5] Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany
    Kuehne, F. C.
    Mittendorf, T.
    Voelkl, M.
    Lipp, R.
    Germing, U.
    Vioni-Niemeyer, A.
    Von der Schulenburg, J. M.
    VALUE IN HEALTH, 2007, 10 (06) : A282 - A282
  • [6] Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany
    Kuehne, C.
    Mittendorf, T.
    Voelk, M.
    Lipp, R.
    Gerning, U.
    Vionniemeyer, A.
    von der Schulenberg, J. M. Graf
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 547 - 547
  • [7] Iron chelation therapy in patients with transfusion-dependent myelodysplastic syndrome
    Mast, Alan E.
    Field, Joshua J.
    TRANSFUSION, 2012, 52 (10) : 2078 - 2080
  • [8] Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy
    Efficace, Fabio
    Santini, Valeria
    La Nasa, Giorgio
    Cottone, Francesco
    Finelli, Carlo
    Borin, Lorenza
    Quaresmini, Giulia
    Di Tucci, Anna Angela
    Volpe, Antonio
    Cilloni, Daniela
    Quarta, Giovanni
    Sanpaolo, Grazia
    Rivellini, Flavia
    Salvi, Flavia
    Molteni, Alfredo
    Voso, Maria Teresa
    Alimena, Giuliana
    Fenu, Susanna
    Mandelli, Franco
    Angelucci, Emanuele
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2016, 6 (01) : 80 - 88
  • [9] Rationale for Therapy Discontinuation in Patients with Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes (MDS)
    Gerds, Aaron T.
    Gupta, Shaloo
    Binder, Gary
    Sekeres, Mikkael A.
    Nazha, Aziz
    Carraway, Hetty E.
    Hawthorne, Stephanie
    King-Concialdi, Kristen
    McGuire, Michael
    BLOOD, 2016, 128 (22)
  • [10] Efficacy and safety of deferasirox (Exjade®) in chelation-naive and previously chelated patients with transfusion-dependent myelodysplastic syndromes (MDS)
    Schmid, M.
    Guerci-Bresler, A.
    Della Porta, M.
    Taylor, K.
    Habr, D.
    Domokos, G.
    Roubert, B.
    Rose, C.
    Gattermann, N.
    LEUKEMIA RESEARCH, 2009, 33 : S141 - S142